With the U.S. healthcare system at an unprecedented crossroads, cancer care has emerged as one of the most hotly debated subjects. Stakeholders include manufacturers, physicians, patients, payers and service providers and even the government itself. And all have their own set of concerns to be addressed.
Join us as we discuss how crucial drivers like health reform, new technology and global economy converge to impact the oncology market. Pharmaceutical Executive Editor-in-Chief Bill Looney visits with Mark Santos, Executive Vice President and General Manager for ION, to discuss this complex industry: